These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16939037)

  • 1. To box OR NOT TO box.
    Newstadt M
    J Ky Med Assoc; 2006 Aug; 104(8):344-5. PubMed ID: 16939037
    [No Abstract]   [Full Text] [Related]  

  • 2. ADHD drugs and cardiovascular risk.
    Rappley MD; Moore JW; Dokken D
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375
    [No Abstract]   [Full Text] [Related]  

  • 3. ADHD drugs and cardiovascular risk.
    Nissen SE
    N Engl J Med; 2006 Apr; 354(14):1445-8. PubMed ID: 16549404
    [No Abstract]   [Full Text] [Related]  

  • 4. Debate over warnings for ADHD stimulants.
    Child Health Alert; 2006 Apr; 24():1. PubMed ID: 16673500
    [No Abstract]   [Full Text] [Related]  

  • 5. ADHD drugs and cardiovascular risk.
    Anders T; Sharfstein S
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16723628
    [No Abstract]   [Full Text] [Related]  

  • 6. Medications for attention deficit hyperactivity disorder: cardiovascular concerns.
    Wooltorton E
    CMAJ; 2006 Jul; 175(1):29. PubMed ID: 16772535
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulant medications and attention deficit-hyperactivity disorder.
    Cohen AL; Jhung MA; Budnitz DS
    N Engl J Med; 2006 May; 354(21):2294-5. PubMed ID: 16723627
    [No Abstract]   [Full Text] [Related]  

  • 8. ADHD black box warning: how concerned should we be?
    Cruz R; Kutscher EC
    S D Med; 2007 Feb; 60(2):63, 65. PubMed ID: 17390569
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulants and sudden death: what is a physician to do?
    Wilens TE; Prince JB; Spencer TJ; Biederman J
    Pediatrics; 2006 Sep; 118(3):1215-9. PubMed ID: 16951018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada.
    Eggertson L
    CMAJ; 2005 Mar; 172(7):865. PubMed ID: 15758187
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrocardiograms for attention deficit disorder.
    Moodie DS
    Congenit Heart Dis; 2008; 3(5):307. PubMed ID: 18837807
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
    Vetter VL; Elia J; Erickson C; Berger S; Blum N; Uzark K; Webb CL; ;
    Circulation; 2008 May; 117(18):2407-23. PubMed ID: 18427125
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
    Perrin JM; Friedman RA; Knilans TK; ;
    Pediatrics; 2008 Aug; 122(2):451-3. PubMed ID: 18676566
    [No Abstract]   [Full Text] [Related]  

  • 17. ADHD treatment and the risk of substance abuse.
    Sircy RA; Stojanoski A
    Nurse Pract; 2008 Apr; 33(4):33-6. PubMed ID: 18388552
    [No Abstract]   [Full Text] [Related]  

  • 18. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B; Towbin K
    Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulants for kids with ADHD--how to proceed safely.
    Ken Mehta S; Jacobs I
    J Fam Pract; 2014 Feb; 63(2):E1-5. PubMed ID: 24527478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.